期刊文献+

新鲜冰冻血浆和血浆冷沉淀的临床运用 被引量:6

The Clinical Application of Fresh Frozen Plasma and Blood Plasma Cryoprecipitate
暂未订购
导出
摘要 输血现代化的重要标志之一是成分输血,成分输血以其针对性强、制品浓度高、疗效好、方便安全、不良反应少、综合利用、节约血源等特点成为当前输血技术发展的总趋势。随着成分输血的广泛应用,新鲜冰冻血浆和血浆冷沉淀的临床应用日益显现出它的重要。现将它们的临床应用作一分析。 Component transfusion is an important symbol of blood transfusion modernization. With its many advantages,such as high pertinence,high concentration of products,satisfying curative effect,superior convenience and safety,low side effects,compre- hensive usage,conservation of blood sources etc,blood component transfusion is becoming the general trend of transfusion technique' s development. As this technique is becoming widely used, clinical application of fresh frozen plasma and blood plasma cryoprecipitate appears to he increasingly important. Now,I'll make an analysis on their clinical application.
作者 张厚勤
出处 《中外医疗》 2009年第28期1-2,共2页 China & Foreign Medical Treatment
关键词 血浆 冷沉淀 临床 适应证 Blood Plasma Cryoprecipitate Clinic Indication
  • 相关文献

参考文献6

二级参考文献70

共引文献51

同被引文献33

  • 1蓝海峰,杨仁池.特发性血小板减少性紫癜发病机制的认识[J].内科急危重症杂志,2006,12(6):258-261. 被引量:11
  • 2兰竹.新鲜冰冻血浆的制备时间对凝血因子Ⅴ和Ⅷ含量的影响[J].广东医学,2007,28(2):262-263. 被引量:6
  • 3Stasi R,Pagano A,Amadoli S.Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura[J].Blood,2001,98:952-957.
  • 4Giagounidis AA,Anthuf J,Schneider Pet al.Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab:a pilot study[J].Eur J Haematol,2002,69:95-100.
  • 5Cooper N,Stasi R,Curninggham-Rundles S,et al.The efficacy and safety of B cell depletion with anti CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura(f)[J].Br J Haematol,2004,125:232-239.
  • 6Stasi R,Stipa E,Forte Vet al.Variable paterns of response to rituximab in adults with chronic idiopathic thrombocytopenic purpura(f)[J].Blood,2002,99:3872-3873.
  • 7陈小伍,于新发,田兆嵩.输血治疗学[M].北京:科学出版社,2012.
  • 8中华人民共和国卫生部医政司.全国临床检验操作规程[M].3版.江苏:东南大学出版社,2010:59-62.
  • 9中华人民共和国卫生部.中国国家标准化委员会.全血及成分血质量要求(GBl8469-2012)[S].北京:中华人民共和国卫生部,2012:11-13.
  • 10中国合格评定国家认可委员会.检测和校准实验室能力认可准则(CNAS-CL01)[S].中国合格评定国家认可委员会,2005:25.

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部